Literature DB >> 7701028

Concurrent validity of the cognitive component of schizophrenia: relationship of PANSS scores to neuropsychological assessments.

M D Bell1, P H Lysaker, R M Milstein, J L Beam-Goulet.   

Abstract

Cognitive symptoms of schizophrenia may represent a separate component of the disorder that is distinct from positive or negative syndromes. In a previous study, we reported a factor analysis of the Positive and Negative Syndrome Scale (PANSS) that revealed five components, one of which we labeled the Cognitive component. In the present study, we explored the validity of the PANSS Cognitive component by examining correlations between neuropsychological measures and the five factor-analytically derived PANSS scores for 147 subjects with diagnoses of schizophrenia or schizoaffective disorder. Higher scores on the PANSS Cognitive component were significantly correlated with poorer performance on all neuropsychological tests, including the Wisconsin Card Sorting Test (WCST), the Digit Symbol Substitution Task, the Slosson Intelligence Test, and the Gorham Proverbs Test. Multiple regression revealed that these test scores explained 37% of the variance in the Cognitive component score. Neuropsychological tests have very limited associations with the other PANSS components. These results suggest that the Cognitive component of the PANSS is a valid measure of cognitive deficits in schizophrenia, and they support the hypothesis that Cognitive impairment is a distinctive feature of schizophrenia independent of positive and negative syndromes.

Entities:  

Mesh:

Year:  1994        PMID: 7701028     DOI: 10.1016/0165-1781(94)90064-7

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  24 in total

1.  Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits.

Authors:  Joseph Ventura; April D Thames; Rachel C Wood; Lisa H Guzik; Gerhard S Hellemann
Journal:  Schizophr Res       Date:  2010-06-25       Impact factor: 4.939

2.  Effects of Δ-THC on Working Memory: Implications for Schizophrenia?

Authors:  Nehal P Vadhan; Mark R Serper; Margaret Haney
Journal:  Prim psychiatry       Date:  2009-01-01

3.  Timing dysfunctions in schizophrenia as measured by a repetitive finger tapping task.

Authors:  Christine A Carroll; Brian F O'Donnell; Anantha Shekhar; William P Hetrick
Journal:  Brain Cogn       Date:  2009-08-06       Impact factor: 2.310

4.  Measuring participation in an evidence-based practice: illness management and recovery group attendance.

Authors:  Alan B McGuire; Kelsey A Bonfils; Marina Kukla; Laura Myers; Michelle P Salyers
Journal:  Psychiatry Res       Date:  2013-09-05       Impact factor: 3.222

5.  The effects of cognitive impairment and substance abuse on psychiatric hospitalizations.

Authors:  C T Jackson; D Fein; S M Essock; K T Mueser
Journal:  Community Ment Health J       Date:  2001-08

6.  Efficacy and tolerability of olanzapine in patients with schizophrenia in lithuania: A 13-week, multicenter, open-label, nonrandomized study.

Authors:  Valentinas Maciulis; Istvan Bitter; Raimundas Milasiunas; Algirdas Dembinskas; Liaudminas Radavicius; Algirdas Kaunas; Martin Dossenbach; Daniel Walker
Journal:  Curr Ther Res Clin Exp       Date:  2004-01

7.  Effects of age of onset on clinical characteristics in schizophrenia spectrum disorders.

Authors:  Yu-Chen Kao; Yia-Ping Liu
Journal:  BMC Psychiatry       Date:  2010-08-18       Impact factor: 3.630

8.  Dual Diagnosis Motivational Interviewing: a modification of Motivational Interviewing for substance-abusing patients with psychotic disorders.

Authors:  Steve Martino; Kathleen Carroll; Demetrios Kostas; Jennifer Perkins; Bruce Rounsaville
Journal:  J Subst Abuse Treat       Date:  2002-12

9.  Exploration of irony appreciation in schizophrenia: a replication study on an Italian sample.

Authors:  Paolo Stratta; Ilaria Riccardi; Daniela Mirabilio; Silvia Di Tommaso; Annerita Tomassini; Alessandro Rossi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-04-26       Impact factor: 5.270

Review 10.  Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective.

Authors:  Julia M Sheffield; Nicole R Karcher; Deanna M Barch
Journal:  Neuropsychol Rev       Date:  2018-10-20       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.